Search by Drug Name or NDC
NDC 35356-0821-30 temazepam 22.5 mg/1 Details
temazepam 22.5 mg/1
temazepam is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quality Care Products LLC. The primary component is TEMAZEPAM.
MedlinePlus Drug Summary
Temazepam is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It works by slowing activity in the brain to allow sleep.
Related Packages: 35356-0821-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Temazepam
Product Information
| NDC | 35356-0821 |
|---|---|
| Product ID | 35356-821_b120edb5-bd7c-481b-8535-0110960e742b |
| Associated GPIs | 60201030000108 |
| GCN Sequence Number | 058570 |
| GCN Sequence Number Description | temazepam CAPSULE 22.5 MG ORAL |
| HIC3 | H21 |
| HIC3 Description | SEDATIVE-HYPNOTICS - BENZODIAZEPINES |
| GCN | 24036 |
| HICL Sequence Number | 001592 |
| HICL Sequence Number Description | TEMAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | temazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | temazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 22.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | TEMAZEPAM |
| Labeler Name | Quality Care Products LLC |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA071457 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 35356-0821-30 (35356082130)
| NDC Package Code | 35356-821-30 |
|---|---|
| Billing NDC | 35356082130 |
| Package | 30 CAPSULE in 1 BOTTLE (35356-821-30) |
| Marketing Start Date | 2012-06-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |